These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

400 related items for PubMed ID: 18342468

  • 1. Extracellular Gd-CA: differences in prevalence of NSF.
    Thomsen HS, Marckmann P.
    Eur J Radiol; 2008 May; 66(2):180-3. PubMed ID: 18342468
    [Abstract] [Full Text] [Related]

  • 2. MRI contrast media are used to improve visualization of abnormal structures or lesions in various parts of the body. Introduction.
    Thomsen HS, Marckmann P.
    Eur J Radiol; 2008 May; 66(2):153-9. PubMed ID: 18343071
    [Abstract] [Full Text] [Related]

  • 3. Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting.
    Broome DR.
    Eur J Radiol; 2008 May; 66(2):230-4. PubMed ID: 18372138
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Nephrogenic systemic fibrosis].
    Breitschaft A, Stahlmann R.
    Med Monatsschr Pharm; 2009 Oct; 32(10):377-82. PubMed ID: 19886227
    [Abstract] [Full Text] [Related]

  • 6. Nephrogenic systemic fibrosis--implications for nephrologists.
    Saab G, Abu-Alfa A.
    Eur J Radiol; 2008 May; 66(2):208-12. PubMed ID: 18342470
    [Abstract] [Full Text] [Related]

  • 7. High prevalence of nephrogenic systemic fibrosis in chronic renal failure patients exposed to gadodiamide, a gadolinium-containing magnetic resonance contrast agent.
    Rydahl C, Thomsen HS, Marckmann P.
    Invest Radiol; 2008 Feb; 43(2):141-4. PubMed ID: 18197066
    [Abstract] [Full Text] [Related]

  • 8. An epidemic outbreak of nephrogenic systemic fibrosis in a Danish hospital.
    Marckmann P.
    Eur J Radiol; 2008 May; 66(2):187-90. PubMed ID: 18328659
    [Abstract] [Full Text] [Related]

  • 9. A preclinical study to investigate the development of nephrogenic systemic fibrosis: a possible role for gadolinium-based contrast media.
    Sieber MA, Pietsch H, Walter J, Haider W, Frenzel T, Weinmann HJ.
    Invest Radiol; 2008 Jan; 43(1):65-75. PubMed ID: 18097279
    [Abstract] [Full Text] [Related]

  • 10. Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue.
    Wiginton CD, Kelly B, Oto A, Jesse M, Aristimuno P, Ernst R, Chaljub G.
    AJR Am J Roentgenol; 2008 Apr; 190(4):1060-8. PubMed ID: 18356456
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Gadolinium-containing magnetic resonance imaging contrast and nephrogenic systemic fibrosis: a case-control study.
    Kallen AJ, Jhung MA, Cheng S, Hess T, Turabelidze G, Abramova L, Arduino M, Guarner J, Pollack B, Saab G, Patel PR.
    Am J Kidney Dis; 2008 Jun; 51(6):966-75. PubMed ID: 18501784
    [Abstract] [Full Text] [Related]

  • 13. Dermal inorganic gadolinium concentrations: evidence for in vivo transmetallation and long-term persistence in nephrogenic systemic fibrosis.
    Abraham JL, Thakral C, Skov L, Rossen K, Marckmann P.
    Br J Dermatol; 2008 Feb; 158(2):273-80. PubMed ID: 18067485
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Nephrogenic systemic fibrosis after application of gadolinium-based contrast agents--a status paper].
    Heinrich M, Uder M.
    Rofo; 2007 Jun; 179(6):613-7. PubMed ID: 17497597
    [Abstract] [Full Text] [Related]

  • 17. MRI gadolinium-based contrast agents. Radiologists beware!
    Goullé JP, Cattanéo A, Saussereau E, Mahieu L, Guerbet M, Lacroix C.
    Ann Pharm Fr; 2009 Sep; 67(5):335-9. PubMed ID: 19695369
    [Abstract] [Full Text] [Related]

  • 18. Nephrogenic systemic fibrosis: a review of 6 cases temporally related to gadodiamide injection (omniscan).
    Khurana A, Runge VM, Narayanan M, Greene JF, Nickel AE.
    Invest Radiol; 2007 Feb; 42(2):139-45. PubMed ID: 17220732
    [Abstract] [Full Text] [Related]

  • 19. A follow-up of four cases of nephrogenic systemic fibrosis: is gadolinium the specific trigger?
    Singh M, Davenport A, Clatworthy I, Lewin J, Deroide F, Hubbard V, Rustin MH.
    Br J Dermatol; 2008 Jun; 158(6):1358-62. PubMed ID: 18363754
    [Abstract] [Full Text] [Related]

  • 20. The impact of NSF on the care of patients with kidney disease.
    Abu-Alfa A.
    J Am Coll Radiol; 2008 Jan; 5(1):45-52. PubMed ID: 18180009
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.